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Abstract—Defining subtypes of complex diseases such as cancer
and stratifying patient groups with the same disease but different
subtypes for targeted treatments is important for personalized
and precision medicine. Approaches that incorporate multi-
omic data are more advantageous to those using only one
data type for patient clustering and disease subtype discovery.
However, it is challenging to integrate multi-omic data as they
are heterogeneous and noisy. In this paper, we present Affinity
Network Fusion (ANF) to integrate multi-omic data for patient
clustering. ANF first constructs patient affinity networks for
each omic data type, and then calculates a fused network for
spectral clustering. We applied ANF to a processed harmonized
cancer dataset downloaded from GDC data portal consisting
of 2193 patients, and generated promising results on clustering
patients into correct disease types. Moreover, we developed a
semi-supervised model combining ANF and neural network for
few-shot learning. In several cases, the model can achieve greater
than 90% acccuracy on test set with training less than 1% of
the data. This demonstrates the power of ANF in learning a
good representation of patients, and shows the great potential of
semi-supervised learning in cancer patient clustering.
Index Terms—Patient clustering, affinity network fusion, neu-
ral network, multi-omic integration, semi-supervised learning,
cancer subtype discovery
I. INTRODUCTION
Cancer patients are heterogeneous and complex. Patients
with cancer from the same primary sites can be very different
from each other in terms of disease progression, response to
treatments, etc. One important task is to further cluster cancer
patients of the same cancer type into subgroups and define
new cancer subtypes with comprehensive molecular signatures
associated with distinct clinical features.
While the omic data collected are comprehensive, they are
heterogeneous and noisy, too. If we use each type of omic
data to cluster patients, we can probably generate different
results. Since each type of omic data may contain some
complementary information about the patients and the dis-
ease, we can perform clustering by integrating multi-omic
data. Consensus clustering [1] and its variants have been
proposed to “synthesize” different clustering results. However,
they only combine the final clustering results generated by
different feature sets, and thus the integration is considered
to be “shallow”. Many methods that have been developed to
integrate multi-omic data directly for patient clustering in the
past several years are either based on probabilistic models
or network models [2]. It has been demonstrated that patient
clustering based on similarity network fusion (SNF) [3] can
often achieve promising results compared with other methods
such as iCluster [4] or KMeans. While SNF works well in
clustering patients, we find that the required computational
operations in SNF can be significantly reduced and simplified
to get a reliable fused affinity network.
Based on SNF, we developed Affinity Network Fusion
(ANF) with several advantages. ANF requires much less
computation while generating as good as or even better results
than those from SNF. ANF provides a more general framework
for complex object clustering with multi-view data, and can
incorporate view weights. Moreover, we developed a semi-
supervised model combining ANF and Neural Network (NN).
Surprisingly, we can train less than 1% of data and get greater
than 90% accuracy on test set using the output of ANF as input
for a neural network classifier.
We performed extensive experiments on a selected cohort of
2193 cancer patients from four primary sites and nine disease
types. We have achieved high clustering/classification accuracy
both by using ANF and spectral clustering without any training
(i.e., zero-shot learning) and by training only a few labeled
examples with our semi-supervised model (i.e., few-shot learn-
ing). The results demonstrate the power of ANF in learning
good patient representations for clustering/classification pur-
pose.
A. Related Work
Mining multi-omic data has been a hot topic in recent
years [2], [5]. Many approaches are based on probabilistic
modeling usually involving a set of latent variables with a prior
distribution. For instance, iCluster [4], a widely used cancer
patient clustering method, assumes different types of omic data
share a common latent feature space that can be jointly learned
from multi-omic data. KMeans clustering is then performed
on the learned latent features. Other approaches incorporate
domain knowledge such as biological networks into probabilis-
tic modeling. For instance, PARADIGM [6] converted NCI
pathway databases into a factor graph in which each gene is a
factor incorporating several kinds of information, a “natural”
way for integrating multi-omic data.
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As it is challenging to define a proper prior distribution and
learn a good posterior distribution with limited data, many
other approaches do not use probabilistic modeling. For ex-
ample, Similarity Network Fusion (SNF) [3] constructs patient
similarity networks using different types of omic features,
and fuses multiple patient similarity networks to achieve a
“consensus” network that is then used for clustering patients
into disease subtypes.
Based on the main idea of SNF [3], we developed a simpler
and more general framework, Affinity Network Fusion (ANF),
to combine multiple networks into a fused consensus network.
The fused network captures complementary information from
multiple views and is much more robust to noise than individ-
ual networks learned from each view.
II. AFFINITY NETWORK FUSION (ANF)
ANF differs from clustering methods that directly operate
on patient-feature matrix, e.g., KMeans, in that it applies graph
clustering to a constructed patient affinity/similarity matrix
instead of patient-feature matrix. Thus the success of ANF
relies on the construction of an “accurate” patient affinity
network that incorporates information from multiple views.
As multi-omic data are heterogeneous, we first construct
a patient affinity network from each view (i.e., an -omic
data source), and then fuse all individual networks to get a
more robust one. In order to make patient affinity network
robust to noise, we mainly employ two nonlinear k-Nearest-
Neighbor(kNN)-based transformations: kNN Gaussian kernel
and kNN graph. In the following we briefly describe the entire
network construction and fusion process from raw patient-
feature matrices to fused patient affinity network.
A. Construct Patient kNN Affinity Networks
Suppose there are N patients and n views (i.e., omic
feature spaces). Let X (v), v = 1, 2, · · · , n, be n patient-feature
matrices. For example, X (1) might be a gene expression
matrix with rows corresponding to patients (or samples) and
columns corresponding to gene expression measurements (e.g.,
FPKM values). Since omic data are usually high dimen-
sional and noisy, feature selection and transformation [7],
[8] is often needed to transform raw patient-feature matrices
X (v), v = 1, 2, · · · , n into processed patient-feature matrices
X(v), v = 1, 2, · · · , n.
One simple way to integrate multi-view data is simply con-
catenating all individual feature matrices X(v), v = 1, 2, · · · , n
into a single matrix. However, features from different views
may follow different distributions and have different scales.
It is possible that features from some views dominate others,
making the integration less effective. In our approach, we first
process individual views separately to generate patient affinity
networks and then combine them through network fusion, thus
avoiding dealing with heterogeneous feature spaces directly.
For each view v, we first calculate a pair-wise patient dis-
tance matrix ∆(v) = (δ(v)ij )N×N based on processed patient-
feature matrix X(v) using a certain distance metric such as
Euclidean distance, and then calculate kNN Gaussian kernel
and kNN graph to get patient affinity matrix.
1) kNN Gaussian Kernel: With pair-wise distance matrix
∆(v), we can construct corresponding patient similarity net-
work S(v) in multiple ways. For example [9],
• -neighborhood graph (unweighted): connect two patients
if and only if the distance between them is smaller than
. The choice of  is problem-dependent.
• k-nearest-neighbor graph (unweighted): Connect each pa-
tient with his or her k nearest neighbors. k is a parameter
to tune.
• Fully connected graph (weighted): connect all patients
with weighted edges. Edge weights can be calculated
using some kernel such as Gaussian kernel.
Here we combine local Gaussian kernel and kNN graph to
define a kNN Gaussian kernel (the idea is from [3]):
µi =
∑
l∈Nk(i) δil
k
(1)
σij = α(µi + µj) + βδij (2)
Kij =
1√
2piσij
e
− δ
2
ij
2σ2
ij (3)
In Eq. 1, Eq. 2 and Eq. 3, we omit the superscript (i.e.,
·(v)) for simplicity (For example, δij represents δ(v)ij , the
distance between patient i and j calculated from view X(v)).
In Eq. 1, Nk(i) represents the indexes of k-nearest neighbors
of patient i. The choice of k is important and needs to be
tuned. µi represents the local diameter of node i. σij in
Eq. 2 incorporates both local diameters of patient i and j and
their distance. Eq. 3 calculates kNN Gaussian kernel between
patient i and j, with σij defined as Eq. 2, to incorporate local
network structure.
2) kNN Graph: We can regard K(v)ij (Eq. 3) as an unnor-
malized similarity measure between patient i and j from view
v. We further normalize K(v)ij to S
(v)
ij by Eq. 4. As each row
of S(v) = (S(v)ij )N×N sums to 1, S
(v)
ij can be regarded as
normalized similarity measure between patient i and j in view
v, or the probability of (the state of) patient i transitions to
(the state of) patient j in view v.
S
(v)
ij =
K
(v)
ij∑N
j=1K
(v)
ij
, 1 ≤ i, j ≤ N (4)
a) Further Prune “Weak” Edges: S(v) represent a fully
connected affinity network (with positive edges between every
patient pairs). Since edges with small weights are more likely
to be noise, we prune “weak” edges by constructing a kNN
graph from S(v) (Eq. 5).
W
(v)
ij =

(1− ) S
(v)
ij∑
j∈Nk(i) S
(v)
ij
, if j ∈ Nk(i)

S
(v)
ij∑
j /∈Nk(i) S
(v)
ij
, otherwise
(5)
In Eq. 5, Nk(i) again refers to the indexes of k nearest
neighbors of patient i.  is a very small number. We can set
 = 0, then for each row of W(v), only k elements are non-
zero, and only the weights of k nearest neighbors are used for
normalization.
In fact W(v) can be seen as a trunked version of S(v) by
“reducing or throwing away” weak signals (i.e., small edge
weights) in S(v). Thus W(v) should be more robust to small
noise. Since each row of W(v) sums to 1, it can also be
regarded as a state transition matrix.
B. Fuse Multiple Affinity Networks
Suppose there are n views to be combined. Let w =
(w1, w2, · · · , wn) be the view weights. (If the view weights
are not given, we usually start with uniform weights, and tune
the weights with semi-supervised learning.) We can calculate
a weighted view by Eq. 6
W =
n∑
v=1
wv ·W(v)
n∑
v=1
wv = 1, wv ≥ 0
(6)
As W(v) is row-normalized (Eq. 5), the fused view W
(Eq. 6) is also row-normalized (each row sums to 1), and can
be regarded as a state transition matrix. In Eq. 7, we multiply
W by itself r times, and get a smoothed version of transition
matrix. This process can be interpreted as r-step random walk
on a patient affinity network.
W∗ = Wr (7)
In Eq. 7, if r is large enough, W∗ will reach certain
stationary point [9] and become rank 1 (all rows become the
same vector). However, it is not desirable for r to be too large.
We can achieve good results in our experiments on TCGA
data by setting r = 1 (simply Eq. 6) and r = 2. If we keep
increasing r, the results will not change dramatically in the
beginning, but will deteriorate when r becomes too large (e.g.,
r > 10).
In the following we will discuss a slightly modified formu-
lation of Eq. 7 when r = 1, 2.
1) Alternative Formulation of Affinity Network Fusion for
Special Cases: In Eq. 6, we only used W(v) to get a
aggregated view. Sometimes the pruned weak edges might be
useful, too. In Eq. 8, we include S(v) as well.
W(v) = β1W
(v) + β2W(−v) + β3S(v) + β4S(−v)
4∑
v=1
βv = 1, βv ≥ 0
(8)
W(−v) =
∑
i 6=v
wi∑
j 6=v wj
·W(i)
S(−v) =
∑
i 6=v
wi∑
j 6=v wj
· S(i)
(9)
In Eq. 8, W(−v) and S(−v) represent a weighted comple-
mentary view from n−1 other views as defined in Eq. 9. Eq. 8
can be interpreted as network diffusion between view v and
other complementary views, resulting in a smoother version of
W(v). In practice, since W(v) is usually more robust to noise
than S(v), we often set β3 = β4 = 0, in which case Eq. 8 is
equivalent to Eq. 6.
Inspired by Similarity Network Fusion [3], we can define a
more complex fusion process as Eq. 10.
W(v) =α1W
(v) ·W(−v) + α2W(−v) ·W(v)+
α3W
(v) · S(−v) + α4S(−v) ·W(v)+
α5S
(v) ·W(−v) + α6W(−v) · S(v)+
α7S
(v) · S(−v) + α8S(−v) · S(v)
(10)
∑8
i=1 αi = 1, αi ≥ 0
In Eq. 10, W(−v) and S(−v) are defined the same as Eq. 9.
Eq. 10 is roughly equivalent to Eq. 7 when r = 2. The first
term α1W(v) ·W(−v) can be interpreted as a two-step random
walk (by multiplying two transition matrices): the first step is
a random walk on view v, and the second step is a random
walk on the aggregated complementary view (W(−v), Eq. 9).
The other terms in Eq. 10 can have similar interpretations.
Our experiments on cancer genomic data show that the
terms using W(v) usually works better than using S(v),
suggesting W(v) is more reliable than S(v). In practice, the
default choice is just using the first two terms:
W(v) = αW(v) ·W(−v) + (1− α)W(−v) ·W(v) (11)
Note both Eq. 8 and Eq. 10 can be seen as recursive
formulas. We can iteratively update W(v) until convergence
(usually within a few iterations). However, in practice, it is
not necessary to require convergence, which can be seen as
a stationary state achieved through a sufficient number of
random walks. In fact, we only need to calculate Eq. 8 (which
can be seen as a one-step random walk) and Eq. 10 (which can
be seen as a two-step random walk) once to get “smoothed”
views, and calculate a weighted average of all views as shown
in Eq. 6. This is one major difference from SNF[3], which
requires a number of iterations to update similarity matrix
through multiple matrix multiplications until convergence. By
contrast, ANF essentially only needs one iteration to get as
good as or even better results than SNF [7].
a) Interpretation: Each disease subtype may have its
own molecular signature, which can be represented by a state
space model with a vector of explicit and latent variables.
Fig. 1: Toy example of ANF
Disease subtype discovery is essentially finding a unique state
representation for each subtype. Ideally, patients belonging to a
disease subtype should fall into its corresponding space, and be
near each other, while patients with different disease subtypes
should be far away in their state space representations.
All W(v) and S(v) can be regarded as state transition
matrices learned from multi-view data, and Eq. 6 essentially
computes a weighted state transition matrix W. As patients
with the same disease subtypes will be more likely to stay
in the same state space, Eq. 7 and Eq. 10 will strength the
network modularity: patients belonging to the same group
will have denser edges, while the edges among patients from
different groups will be sparser. The resulted fused network
(Eq. 6) will thus be well suited for graph clustering with its
modular structures corresponding to disease subtypes.
b) Toy example: In order to give a vivid understanding of
the clustering process, we show a toy example in Fig. 1. In this
figure, the nodes with different colors represent five patients.
The edges represent transition probabilities between (the states
of) two patients. The width of an edge shows how strong the
edge is (i.e., edge weight). The first row corresponds to state
transition matrix S(v) calculated from Eq. 4. The second row
corresponds to kNN transition matrix W(v) (trunked version
of S(v)). We can see that the “noisy” edges in S(v) have
been removed from W(v). The third row shows the fused
W, which combines information from all three views. The
goal of spectral clustering is to minimize the total effect of
between-cluster edges, which can be mathematically defined as
normalized graph cut [9]. The spectral clustering result on this
five nodes toy example is shown in the bottom right subfigure.
As we can see three nodes are clustered together (red shaded
area), and the other two are clustered (lightblue shaded area).
The edges within each cluster are relatively stronger compared
with the edges across clusters (red edges in the figure).
The overall unsupervised ANF framework for cancer patient
clustering (zero-shot learning) is summarized in Alg. 1.
Algorithm 1: Unsupervised Affinity Network Fusion for
Clustering
Input : •Patient-feature matrices (n views):
X (v), v = 1, 2, · · · , n
•Number of clusters: c
•Weight of each view (optional):
w = (w1, · · · , wn)
•Other optional parameters
Output: •Patient cluster assignment A
•Fused patient affinity matrix W
•Patient affinity matrices from each view,
W(v), v = 1, · · · , n
begin
Feature selection and transformation
X (v) → X(v) ∈ RN×pv , v = 1, 2, · · · , n
Calculate pair-wise distance matrix for each view:
∆(v) ∈ RN×N+ , v = 1, 2, · · · , n
Calculate kNN affinity matrix for each view:
W(v), v = 1, 2, · · · , n (Eq. 8 or Eq. 10)
Calculate fused affinity matrix W (Eq. 6 or Eq. 7)
Spectral clustering on fused affinity matrix W:
(W, c)→ A
Return A,W,W(v), v = 1, 2, · · · , n
end
III. SEMI-SUPERVISED LEARNING ON PATIENT AFFINITY
NETWORKS
In addition to being a principled method for clustering, ANF
framework (Alg. 1) generates a series of patient kNN affinity
matrices W(v), v = 1, 2, · · · , n, which turn out to be good
representations of patients for the purpose of classification or
clustering. We have designed the following semi-supervised
neural network model to tap the representation power of
patient affinity matrices.
W =
n∑
v=1
wv ·W(v)
Y1 = f(A1W + b1)
Y2 = f(A2Y1 + b1)
(12)
where f(x) = ReLU(x) = max(x, 0) or other nonlinear
activations.
As shown in Fig. 2 and Eq. 12, the input layer is the
concatenated kNN affinity matrices for each view generated
by Alg. 1. Layer 0 calculates a weighted fused view (similar
to attention mechanism). In Eq. 6, we have to manually set
view weights (usually uniformly). Now we can train a neural
network end-to-end to learn these weights automatically.
Layer 1 extracts the hidden representation Y1 from W,
and Layer 2 produces a much lower dimensional hidden
representation Y2 for classification.
The reason we do not want more layers or add advanced
modules such as skip connections [10] is that “class label”
Fig. 2: Semi-supervised clustering with neural network model
information is very expensive in biomedical applications and
we usually have very few training examples. Adding more
layers will increase the risk of overfitting for a few training
examples. Importantly, implicit kNN-based nonlinear transfor-
mations in Alg 1 have already been applied to the original
feature matrices. The input to the neural network, kNN affinity
matrices generated by Alg 1, are already a good representation
of the data. Though very simple, this architecture works
surprisingly well (see Sec. IV).
a) How to Find Examples: While it is costly to assign
class label to all patients, it is feasible to label some patients
as belonging to different groups based on clinical data. For ex-
ample, as most cancer patient clustering methods used clinical
data to validate the clustering results, we can also use clinical
data to “manually” choose some examples. We call examples
chosen using clinical data by experts as “clean” examples.
On the other hand, we can select a few examples with cluster
labels generated by unsupervised ANF framework (Alg. 1) for
training. We call examples with clustering labels generated by
unsupervised learning methods as “noisy examples” since they
may not represent true class labels.
IV. EXPERIMENTAL RESULTS
A. Dataset and Evaluation Metrics
Harmonized cancer datasets were downloaded from Ge-
nomic Data Commons Data Portal (https://portal.gdc.cancer.
gov/). We selected patients with cancers from four cancer
primary sites: adrenal gland, lung, kidney, and uterus. Cancers
from each of these primary sites have more than one disease
types. For example, cancers from adrenal gland has two
disease types: Pheochromocytoma and Paraganglioma (project
TABLE I: Sample information of four cancer types
Cancer type Disease type Total
adrenal gland TCGA-ACC 76 253TCGA-PCPG 177
lung TCGA-LUAD 447 811TCGA-LUSC 364
kidney
TCGA-KICH 65
654TCGA-KIRC 316
TCGA-KIRP 273
uterus TCGA-UCEC 421 475TCGA-UCS 54
name: TCGA-PCPG) and Adrenocortical Carcinoma (project
name: TCGA-ACC). In this paper, for ease of description, we
refer to “cancer types” as cancers from these four primary
sites. We want to cluster patients of the same “cancer types”
into known disease types. Since the disease types are one-to-
one corresponded to TCGA projects. For ease of description,
in the following we use TCGA project names to refer to
disease types.
The number of samples used for analysis in each cancer type
is summarized in Table I (a few “outlier” samples detected by
exploratory data analysis had already been removed). All these
patient samples have gene expression, miRNA expression and
DNA methylation (from HumanMethylation450 array) data
available for both tumor and normal samples.
While our ultimate goal is to detect cancer subtypes (the
true subtypes are not known), it is a good strategy to evalu-
ate disease subtype discovery methods using a dataset with
groundtruth. The dataset used here serves for this purpose
well. Since we have ground truth disease types, we can
evaluate clustering results using external metrics. The metrics
we used to evaluate clustering results include: (1) Normalized
Mutual Information (NMI): NMI(Ω, C) = I(Ω,C)(H(Ω)+H(C))/2 ;
(2) Adjusted Rand Index (ARI) [11].
B. The Power of Affinity Network Fusion (ANF)
In this section we mainly examine the performance of
unsupervised ANF (Alg. 1) without using any labeled data
(i.e., zero-shot learning).
To demonstrate the power of ANF, we compared the clus-
tering results using single data types with those using ANF to
integrate multiple data types. In Fig. 3, we compared seven
different combinations of data types:
• “gene”: gene expression (FPKM values)
• “mirnas”: miRNA expression (normalized counts)
• “methylation”: DNA methylation data (beta values from
Illumina Human Methylation 450 platform)
• “gene+mirnas”: combine “gene” and “mirnas” using ANF
• “gene+methylation”: combine “gene” and “methylation”
using ANF
• “mirnas+methylation”: combine “mirnas” and “methyla-
tion” using ANF
Fig. 3: Power of ANF combining multi-omic data
• “gene+mirnas+methylation”: combine “gene”, “mirnas”,
and “methylation” using ANF
Fig. 3 shows NMI values (between 0 and 1. Larger NMI
value corresponds to better clustering result) of patient clus-
tering results using ANF framework on the aforementioned
seven combinations of data types. (Here we set the number of
clusters to be the number of disease types.)
In general, a combination of at least two data types usually
yields better clustering results. Specifically, for uterus cancer,
clustering using gene or miRNA expression data alone did a
“terrible” job (NMI ≈ 0). However, by integrating the two data
types, the result improves significantly (NMI=0.30), which
demonstrates the power of ANF.
We also find that it is usually not the case that integrating
three data types would generate better results than that from
integrating two data types. One possible reason is that cluster-
ing using DNA methylation beta values performs much better
than using FPKM and normalized miRNA expression values
for all four cancer types, suggesting that DNA methylation
data may contain highly relevant information about disease
types. However, integrating more data types tends to make the
results more robust as “gene+mirna+methylation” consistently
performs relatively well across four cancer types, while two
data type combinations may fail in some cases (for example,
“mirnas+methylation” for uterus cancer does not yield good
clustering results). Very similar results are obtained for using
Adjust Rand Index (ARI) as clustering metric (not shown
here).
ANF can achieve high clustering accuracies for all the
four cancer types (Table II). Code and more comprehen-
sive results can be found in https://github.com/BeautyOfWeb/
Clustering-TCGAFiveCancerTypes. ANF has been accepted
as a Bioconductor package (https://bioconductor.org/packages/
release/bioc/html/ANF.html).
1) Determine the Number of Clusters: Since ANF frame-
work applies spectral clustering to a fused affinity matrix, we
can use eigengap heuristic or more advanced technique [12] to
determine the number of clusters and indirectly assess cluster
TABLE II: Clustering accuracy of four cancer types
Adrenal gland Lung Kidney Uterus
NMI 0.96 0.75 0.84 0.61
ARI 0.98 0.83 0.91 0.78
Fig. 4: Eigenvalues of affinity matrix of four cancer types
quality. For simplicity, we only discuss eigengap heuristic
here.
The fused patient affinity matrix W generated by ANF is
a state transition matrix, and is asymmetric in most cases.
We chose the affinity matrices that achieve best clustering
accuracies for four cancer types, and calculated the eigenvalues
of the corresponding normalized graph Laplacian of these
matrices (shown in Fig. 4). We found eigengap heuristic is
very useful for deciding the number of clusters. For example,
the first two smallest eigenvalues for adrenal gland are very
near 0, while the third one is about 0.2. The eigengap between
the second and third smallest values is relatively large. This
suggests there should be two “natural” clusters (corresponding
to the two nearly 0 eigenvalues). Furthermore, the eigengap
between the fourth and third values is relatively high, too. This
suggests we can use the learned affinity matrix for disease
subtype discovery for adrenal gland cancer. In fact, when we
set the number of clusters to be 3, our framework will separate
176 “TCGA-PCPG” samples into two groups consisting 155
samples and 21 samples respectively. If we set the number of
clusters to 4, the 155 samples will be further split into two
small groups as shown in Table. III.
Analysis for other cancer types are similar and omitted
here. With fused affinity matrix generated by ANF, users can
calculate the eigenvalues of its normalized graph Laplacian,
and use eigengap heuristic or more advanced techniques such
as [12] to determine the number of clusters.
C. Neural Network Semi-supervised Learning
In this section, we switch gear to examine the performance
of a semi-supervised learning model that combines ANF and
neural network. Fig. 2 shows the model architecture. We feed
the output of ANF, i.e., kNN affinity matrices, to a neural
TABLE III: Confusion matrix of clustering adrenal gland
#Clusters TrueClass Clusters
2
C1 C2
TCGA-ACC 0 76
TCGA-PCPG 176 1
3
C1 C2 C3
TCGA-ACC 0 0 76
TCGA-PCPG 155 21 1
4
C1 C2 C3 C4
TCGA-ACC 0 0 76 0
TCGA-PCPG 83 21 1 72
5
C1 C2 C3 C4 C5
TCGA-ACC 0 0 30 46 0
TCGA-PCPG 83 21 0 1 72
network, and train the neural network with a few labeled
examples (i.e., few-shot learning).
1) Few-shot Learning: Training With A Few Examples: We
used the same architecture in Fig. 2 and parameter settings
for all four cancer types. The numbers of hidden units in
Layer 0, 1, 2 are equal to the number of patients, 50, and the
number of clusters (either 2 or 3), respectively. We used Adam
optimizer with learning rate = 0.05, learning rate decay = 0.9
(decay learning rate every 10 iterations), maximum number of
iterations = 100.
a) Training examples: Since we have true disease type
information, we can randomly select a few examples with true
class labels. We call these examples as “clean” examples.
Meanwhile, we use ANF Alg. 1 with uniform view weights
to generate clustering results, and randomly select a few ex-
amples with cluster labels for training. We call these examples
as “noisy” examples.
In the following we randomly selected an incremental
number of clean or noisy examples from less than 1% to 50%
for training, and ran experiments five times and reported the
best NMI (normalized mutual information) values for test sets
(The training accuracy is 100% for most of the times).
Fig. 5 shows that training with “clean” examples performs
slightly better than “noisy” examples, especially for uterus
and kidney cancer. Even “noisy” examples work well because
that they are generated by unsupervised ANF and are in fact
correct in most cases. Amazingly, training with only two
clean examples for adrenal gland cancer achieves NMI ≥
0.8 (accuracy ≥ 97%). With only 10 training examples, the
NMI value becomes larger than 0.9. Overall as the number of
training examples increases, the performance improves except
training uterus cancer with noisy examples.
Usually with few training examples and high dimensional
features, it is not possible to achieve high test set accuracy.
However, due to the good representation learned by Alg. 1 as
the initial input for neural network, we can avoid overfitting
and achieve surprisingly good results on test set with less than
1% of training examples.
How Does the Classifier Work Internally?
To see why training with only one example each class can
achieve such high accuracy in adrenal gland cancer (results
for other cancer types are similar and not shown here), we
visualize the internal states of Layer 1 and Layer 2 both
before and after training. Layer 1 has 50 dimensions, we used
PCA for dimensionality reduction.
In Fig. 6, each data point corresponds to a patient and is
colored blue or cran corresponding to the true class label. The
two examples used for training are colored yellow and red. As
we can see, the state of second to last layer and the last layer
are both random before training due to random initialization
of model parameters. The two training examples “drag” all the
samples of its class to its side during training. After training,
we can clearly see two linearly separable clusters.
2) Finetune Clustering Result: Our framework not only fa-
cilitates few-shot learning, but can learn a good representation
for transfer learning as well. We demonstrate this with the
following experiments on kidney cancer dataset.
Kidney cancer has three disease types. We first select a few
examples from only two disease types and train the model
(Fig. 2). Even though trained on only two disease types, we
expect the model to be able to learn a good representation
that may reflect three natural clusters. In order to test this, we
“freeze” the model parameters in lower layers, and finetune the
last layers of the model with both clean and noisy examples
(which are again obtained through unsupervised ANF and
spectral clustering) from all three disease types.
Fig. 7 shows that finetuning model significantly improves
performance after initially training with examples from only
two disease types (downward yellow triangle in the figure).
This means the learned patient representation (which has been
“freezed” during finetuning) is good enough to reflect the three
true clusters even though we only trained on two clusters for
learning a representation.
In addition, we trained our model using two views
(“gene+mirnas”, results shown in the upper panel of Fig. 7)
and three views (“gene+mirnas+methylation”, results shown
in the lower panel of Fig. 7), and finetuned the last layer only
(upward green triangle in Fig. 7) and the last two layers (filled
red circle in Fig. 7). We found that finetuning the second to
last layer performs slightly better than finetuning only the last
output layer, especially when there are more views (as shown
in the lower left panel of Fig. 7), suggesting the second to last
layer may be more useful for transfer learning.
V. DISCUSSION AND CONCLUSION
Defining cancer subtypes and identifying subtype-specific
molecular signatures associated with clinical variables is one
major goal for cancer genomics. In this paper, we presented
both unsupervised and semi-supervised affinity network fusion
(ANF) framework that can integrate multi-omic data for cancer
patients clustering and subtype discovery.
We used the newest release of harmonized cancer datasets
from Genomic Data Commons Data Portal (since the data is
harmonized, it is of high quality for large-scale integration),
and selected 2193 cancer patients from four primary sites
(a) 253 adrenal gland cancer samples (b) 475 uterus cancer samples
(c) 811 lung cancer samples (d) 654 kidney cancer samples
Fig. 5: Training NN classifier with very few examples
with known disease types. The experimental results on this
relatively large dataset (2193 cancer patients with gene ex-
pression, miRNA expression and DNA methylation data) are
very promising. The learned fused affinity matrices for the
selected four cancer types matched well with both true class
labels and the theory of spectral clustering based on eigengap
analysis, which can be reliably used for unknown cancer
subtype discovery and identifying subtype-specific molecular
signatures.
While ANF itself can be used for unsupervised, zero-
shot learning (i.e., cluster patients without any training ex-
amples), we further developed a semi-supervised learning
model combining ANF and neural network, which achieved
very good results for few-shot learning (e.g., being able to
achieve 97% accuracy on test set with training less than 1%
of data for classifying patients into correct disease types).
This results from the good representation learned by ANF
through effective kNN-based nonlinear transformations that
reduce noise in multi-omic data. Our work shows the potential
for combining supervised and unsupervised learning through
good representation learning.
While we only reported experimental results on four cancer
types with known disease types, ANF can be used for dis-
covering subtypes of other cancers, and more generally, for
complex object clustering with multi-view feature matrices.
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